P1/2 data • Clinical Trial,Phase I • Clinical Trial,Phase II • Journal • PD(L)-1 Biomarker • IO biomarker
|
CD8 (cluster of differentiation 8) • LAG3 (Lymphocyte Activating 3)
|
CD8 expression • LAG3 expression
|
spartalizumab (PDR001) • ieramilimab (LAG525)